The RAPS learning platform provider will be upgrading its security posture. This will take the system off-line from 20 July through the end of the day 23 July. This will affect any Online Course, eBook, and Virtual Program Attendance. Thank you for your patience.
FDAAA and the Office of New Drugs: An Interview with Dr. John Jenkins.
Posted 01 May 2009 | By
On 5 March, Dr. John Jenkins, director of the US Food and Drug Administration's Office of New Drugs, took the time to answer some questions on the Food and Drug Administration Amendments Act posed by the RAPS Board of Editors.